LC-MS/MS metabolomics profiling of Glechoma hederacea L. methanolic extract; in vitro antimicrobial and in vivo with in silico wound healing studies on Staphylococcus aureus infected rat skin wound

LC-MS/MS analysis of Glechoma hederacea L. methanolic extract (GHME), revealed the identification of 25 metabolites. Ursolic acid (1), 2α-hydroxyursolic acid or corosolic acid (2), 2β-hydroxyursolic acid or epi-corosolic (3), luteolin 7-O-β-D-glucopyranoside (4) and rosmarinic acid (5) were isolated and identified using spectroscopy. Antibacterial activity of GHME against multi drug resistance Staphylococcus aureus clinical isolates was measured. Minimum inhibitory concentrations (MICs) were ranged from 62.5 to 500 µg/ml. In vivo wound healing potential of 2%, and 5% GHME prepared hydrogels were criticized on Staphylococcus aureus infected wound rat model. 5% GHME prepared hydrogel treated group showed significant (p < 0.05) shrinkage of their colony forming unit/ml (CFU/ml) values in comparison with standard Fucidin. Meanwhile, wound closure associated with full re-epithelization and hair follicles proliferation was noticed after ten days of treatment. Finally, among the GHME isolated compounds, luteolin 7-O-β-D-glucopyranoside (4) exhibited the highest molecular docking score (-9.6 kcal/mol) against matrix metalloproteinase-8 target (MMP-8).

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:37

Enthalten in:

Natural product research - 37(2023), 10 vom: 12. Mai, Seite 1730-1734

Sprache:

Englisch

Beteiligte Personen:

El-Aasr, Mona [VerfasserIn]
Nohara, Toshihiro [VerfasserIn]
Ikeda, Tsuyushi [VerfasserIn]
Abu-Risha, Sally E [VerfasserIn]
Elekhnawy, Engy [VerfasserIn]
Tawfik, Haytham O [VerfasserIn]
Shoeib, Nagwa [VerfasserIn]
Attia, Ghada [VerfasserIn]

Links:

Volltext

Themen:

Anti-Bacterial Agents
Anti-Infective Agents
Glechoma hederacea L.
In vivo wound healing studies
Journal Article
KUX1ZNC9J2
LC-MS/MS
Luteolin
Luteolin 7-O-β-D-glucopyranoside
Matrix metalloproteinase-8 target
Multidrug resistance
Plant Extracts
Staphylococcus aureus

Anmerkungen:

Date Completed 20.04.2023

Date Revised 20.04.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/14786419.2022.2108421

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM344623092